Patents by Inventor Michael Boll
Michael Boll has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 10640300Abstract: A system and method for defined aligning of an object. A first object with a first alignment is fed. The first alignment is detected and transmitted to a control device. The control device determines a first rotation angle on the basis of the first alignment and a predefined first alignment, and a speed profile of a first translational movement for a first rotor with a differential speed between the guiding device and the first rotor on the basis of the first rotation angle and a predefined speed of the guiding device. The control device controls the first rotor in the first translational movement along the aligning zone on the basis of the determined speed profile, and the first rotor, in interaction with the guiding device, turns the first object to the first predefined alignment in a first rotation about the first rotation angle on the basis of the differential speed.Type: GrantFiled: August 20, 2018Date of Patent: May 5, 2020Assignee: Beckhoff Automation GmbHInventors: Jan Achterberg, Michael Boll, Andreas Sinzenich
-
Publication number: 20190055091Abstract: A system and method for defined aligning of an object. A first object with a first alignment is fed. The first alignment is detected and transmitted to a control device. The control device determines a first rotation angle on the basis of the first alignment and a predefined first alignment, and a speed profile of a first translational movement for a first rotor with a differential speed between the guiding device and the first rotor on the basis of the first rotation angle and a predefined speed of the guiding device. The control device controls the first rotor in the first translational movement along the aligning zone on the basis of the determined speed profile, and the first rotor, in interaction with the guiding device, turns the first object to the first predefined alignment in a first rotation about the first rotation angle on the basis of the differential speed.Type: ApplicationFiled: August 20, 2018Publication date: February 21, 2019Inventors: Jan Achterberg, Michael Boll, Andreas Sinzenich
-
Publication number: 20160051506Abstract: The present invention relates to a pharmaceutical formulation for the prophylaxis and treatment of critical illness polyneuropathy (CIP) and critical illness myopathy (CIM). The invention further relates to an isotonic fat emulsion comprising at least one triglyceride that comprises at least one fatty acid group having an odd number of carbon atoms, wherein the fatty acid group comprises a carbon chain having 5 to 15 carbon atoms.Type: ApplicationFiled: November 3, 2015Publication date: February 25, 2016Inventor: Michael Boll
-
Patent number: 8569480Abstract: Described are a hydroxyethylstarch, a process for the preparation thereof, a pharmaceutical formulation containing such a hydroxyethylstarch, and the use of the pharmaceutical formulation for the preparation of a volume replacement, a plasma replacement or a plasma volume expander, as well as the use of the pharmaceutical formulation for maintaining normovolemia and/or for improving the macro- and microcirculation and/or for improving the nutritive oxygen supply and/or for stabilizing hemodynamics and/or for improving the volume efficiency and/or for reducing the plasma viscosity and/or for increasing anemia tolerance and/or for hemodilution, especially for therapeutic hemodilution in disturbed blood supply and arterial, especially peripheral arterial, occlusive diseases.Type: GrantFiled: August 4, 2010Date of Patent: October 29, 2013Assignee: B. Braun Melsungen AGInventors: Michael Boll, Andreas Fisch, Donat R. Spahn
-
Patent number: 8445029Abstract: The present invention describes a balanced aqueous electrolyte solution. In particular, a balanced aqueous electrolyte solution that is particularly suitable as a solution for intravenous and subcutaneous infusion because of its being plasma-adapted is described. In addition to the balanced electrolyte solution itself, an electrolyte mixture as well as a process for preparing the balanced electrolyte solution from this mixture, and a medicament comprising the solution and optionally an active ingredient are provided.Type: GrantFiled: March 8, 2010Date of Patent: May 21, 2013Assignee: B. Braun Melsungen AGInventor: Michael Boll
-
Publication number: 20110311644Abstract: The present invention describes a balanced aqueous electrolyte solution. In particular, a balanced aqueous electrolyte solution that is particularly suitable as a solution for intravenous and subcutaneous infusion because of its being plasma-adapted is described. In addition to the balanced electrolyte solution itself, an electrolyte mixture as well as a process for preparing the balanced electrolyte solution from this mixture, and a medicament comprising the solution and optionally an active ingredient are provided.Type: ApplicationFiled: March 8, 2010Publication date: December 22, 2011Applicant: B. BRAUN MELSUNGEN AGInventor: Michael Boll
-
Publication number: 20110207819Abstract: The present invention relates to a pharmaceutical preparation for the prophylaxis and treatment of critical illness polyneuropathy (CIP) and critical illness myopathy (CIM). The invention further relates to an isotonic fat emulsion comprising at least one triglyceride that comprises at least one fatty acid group having an odd number of carbon atoms, wherein the fatty acid group comprises a carbon chain having 5 to 15 carbon atoms.Type: ApplicationFiled: November 9, 2009Publication date: August 25, 2011Applicant: B. BRAUN MELSUNGEN AGInventor: Michael Boll
-
Patent number: 7863260Abstract: Described are a hydroxyethylstarch, a process for the preparation thereof, a pharmaceutical formulation containing such a hydroxyethylstarch, and the use of the pharmaceutical formulation for the preparation of a volume replacement, a plasma replacement or a plasma volume expander, as well as the use of the pharmaceutical formulation for maintaining normovolemia and/or for improving the macro- and microcirculation and/or for improving the nutritive oxygen supply and/or for stabilizing hemodynamics and/or for improving the volume efficiency and/or for reducing the plasma viscosity and/or for increasing anemia tolerance and/or for hemodilution, especially for therapeutic hemodilution in disturbed blood supply and arterial, especially peripheral arterial, occlusive diseases.Type: GrantFiled: March 1, 2005Date of Patent: January 4, 2011Assignee: B. Braun Melsungen AGInventors: Michael Boll, Andreas Fisch, Donat R. Spahn
-
Publication number: 20100298266Abstract: Described are a hydroxyethylstarch, a process for the preparation thereof, a pharmaceutical formulation containing such a hydroxyethylstarch, and the use of the pharmaceutical formulation for the preparation of a volume replacement, a plasma replacement or a plasma volume expander, as well as the use of the pharmaceutical formulation for maintaining normovolemia and/or for improving the macro- and microcirculation and/or for improving the nutritive oxygen supply and/or for stabilizing hemodynamics and/or for improving the volume efficiency and/or for reducing the plasma viscosity and/or for increasing anemia tolerance and/or for hemodilution, especially for therapeutic hemodilution in disturbed blood supply and arterial, especially peripheral arterial, occlusive diseases.Type: ApplicationFiled: August 4, 2010Publication date: November 25, 2010Inventors: Michael Boll, Andreas Fisch, Donat R. Spahn
-
Publication number: 20070282014Abstract: Described are a hydroxyethylstarch, a process for the preparation thereof, a pharmaceutical formulation containing such a hydroxyethylstarch, and the use of the pharmaceutical formulation for the preparation of a volume replacement, a plasma replacement or a plasma volume expander, as well as the use of the pharmaceutical formulation for maintaining normovolemia and/or for improving the macro- and microcirculation and/or for improving the nutritive oxygen supply and/or for stabilizing hemodynamics and/or for improving the volume efficiency and/or for reducing the plasma viscosity and/or for increasing anemia tolerance and/or for hemodilution, especially for therapeutic hemodilution in disturbed blood supply and arterial, especially peripheral arterial, occlusive diseases.Type: ApplicationFiled: March 1, 2005Publication date: December 6, 2007Inventors: Michael Boll, Andreas Fisch, Donat Spahn
-
Patent number: 5874470Abstract: Isotonic fat emulsions are provided which incorporate .omega.-3-fatty acids, .omega.-6-fatty acids, and medium-chain triglycerides. The emulsions are useful for parenteral application in post-aggression metabolism, in cases of chronic inflammatory diseases, and in neonatology and pediatrics. Due to the combination of .omega.-3-fatty acids and/or their physiologically acceptable esters with medium-chain-triglycerides, the medium-chain triglycerides are preferred to be oxidized in the organism, and the .omega.-3 fatty acids are protected from rapid oxidation, so that they are available to a higher extent for the formation of triply unsaturated eicosanoids. Furthermore, a liver protective effect is attained by the combination.Type: GrantFiled: September 6, 1994Date of Patent: February 23, 1999Assignee: B. Braun Melsungen AGInventors: Joerg Nehne, Michael Boll